Reappraisal of the Role of Dolasetron in Prevention and Treatment of Nausea and Vomiting Associated With Surgery or Chemotherapy

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s15545
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Rolapitant in the Treatment of Nausea and Vomiting Associated With Chemotherapy

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2017English

Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

Malignant tumours
2018English

Treatment of Nausea and Vomiting During Chemotherapy

Oncology & Hematology Review (US)
2011English

Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Betamethasone in Prevention of Postoperative Nausea and Vomiting Following Breast Surgery

Journal of Clinical Anesthesia
AnesthesiologyPain Medicine
2014English

The Effectiveness of Ginger in the Prevention of Nausea and Vomiting During Pregnancy and Chemotherapy

Integrative Medicine Insights
Alternative MedicineComplementary
2016English

A Double-Blind, Multicentre Comparison of Intravenous Dolasetron Mesilate and Metoclopramide in the Prevention of Nausea and Vomiting in Cancer Patients Receiving High-Dose Cisplatin Chemotherapy

Supportive Care in Cancer
Oncology
1997English

Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: Approval and Efficacy

Cancer Management and Research
Oncology
2009English

Prevention of Postoperative Nausea and Vomiting With Antiemetics in Patients Undergoing Middle Ear Surgery

Archives of Otolaryngology–Head & Neck Surgery
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy